What we Offer
Our goal is to create new business in the life science space. We do this by exploring and testing new game-changing business models in collaboration with partners. We are continuously expanding our network of partners and key opinion leaders in our innovation target areas. We possess comprehensive expertise in business, product management and development, marketing, IP, finance and investment, and life science applications, such as molecular biology.
Investment scope and typical terms
Typical investment terms:
- Market segments: Life science tools and solutions, for research-use-only or having down stream clinical applications
- Regional focus: North America and Europe
- Investment stages: (Late) seed, (pre-)series A and series B
- Minority investments: Up to 20%, as lead or follower, co-investments with other (financial) VCs possible, seeking board seat
- Investment size: Up to 5 Mio. € per project and round
Our Investment Target Areas
Molecular biology
✔ Genomics, Transcriptomics, Proteomics
✔ Plug-and-play workflow automation
✔ End-to-end workflow solutions
Digital solutions
✔ Data driven business models in Life Science labs
✔ AI/self learning systems
✔ Process control, monitoring & digital workflow execution
✔ Data driven analysis to improve reproducibility and gain efficiency
Cell biology
✔ Cell & gene therapy (CGT)
✔ Cell characterization & cell line development
✔ Cell culturing, separation & purification
✔ Cell expansion, differentiation
✔ Process development, monitoring, control, analytics
